Skip to main content
. Author manuscript; available in PMC: 2010 May 15.
Published in final edited form as: Clin Cancer Res. 2009 Oct 27;15(22):6993–7002. doi: 10.1158/1078-0432.CCR-09-0991

Figure 4. Tumor Expression of NKG2D Ligands Decreases as Tumor Grade Increases.

Figure 4

The graphs above show the number of patients classified as low or high expression represented as a percentage of the total for each TNM stage where stages 0 and 1 were classified together as 1. Stages 2, 3, and 4 were left as individual groups.